Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-001857
NCT ID: NCT02132325
Sponsor Protocol Number: 14-001857
About this study
This study will evaluate feasibility and acceptability of providing the Dignity Therapy/Life Plan intervention to pancreatic or advanced lung cancer patients presenting for treatment in the outpatient medical oncology setting. Investigators hypothesize that providing dignity therapy to this population will be feasible.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Age >18
- Undergoing chemotherapy for pancreatic adenocarcinoma or advanced NSCLC (pancreatic arm closed)
- English-speaking
- Cognitively intact, per clinician judgment, as documented in electronic medical record (EMR)
Exclusion Criteria:
- Currently receiving hospice or palliative care services
- Concurrent diagnosis of delirium or dementia, per medical record
- Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record
- Participating in other psychosocial intervention research studies
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Ann Dose, Ph.D., R.N. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available